Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 128441-99-6 | MDL No. : | MFCD30530176 |
Formula : | C14H21NO3S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BALAVPVKVQRBKA-MJVIPROJSA-N |
M.W : | 283.39 g/mol | Pubchem ID : | 10859008 |
Synonyms : |
1. (S)-(+)-(2-Methylacryloyl)-2,10-camphorsultam |
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.79 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 78.05 |
TPSA : | 62.83 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.28 cm/s |
Log Po/w (iLOGP) : | 2.44 |
Log Po/w (XLOGP3) : | 2.46 |
Log Po/w (WLOGP) : | 2.63 |
Log Po/w (MLOGP) : | 1.27 |
Log Po/w (SILICOS-IT) : | 1.61 |
Consensus Log Po/w : | 2.08 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.01 |
Solubility : | 0.274 mg/ml ; 0.000967 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.42 |
Solubility : | 0.107 mg/ml ; 0.000377 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.42 |
Solubility : | 1.07 mg/ml ; 0.00378 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 5.01 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1187595-85-2 ]
2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile
Similarity: 0.55
[ 50978-45-5 ]
3-Oxobenzo[d]isothiazole-2(3H)-carbaldehyde 1,1-dioxide
Similarity: 0.63
[ 287953-38-2 ]
tert-Butyl (1-(methylsulfonyl)piperidin-4-yl)carbamate
Similarity: 0.50
[ 1932472-17-7 ]
(3AS,6S,7aS)-8,8-dimethylhexahydro-3H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide
Similarity: 0.65
[ 50978-45-5 ]
3-Oxobenzo[d]isothiazole-2(3H)-carbaldehyde 1,1-dioxide
Similarity: 0.63
[ 108448-77-7 ]
(3aR,6S,7aS)-8,8-Dimethylhexahydro-1H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide
Similarity: 0.58
[ 1036738-82-5 ]
1-(Cyclopropylsulfonyl)piperidine-4-carbonitrile
Similarity: 0.57
[ 1932472-17-7 ]
(3AS,6S,7aS)-8,8-dimethylhexahydro-3H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide
Similarity: 0.65
[ 108448-77-7 ]
(3aR,6S,7aS)-8,8-Dimethylhexahydro-1H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide
Similarity: 0.58
[ 1036738-82-5 ]
1-(Cyclopropylsulfonyl)piperidine-4-carbonitrile
Similarity: 0.57
[ 1187595-85-2 ]
2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile
Similarity: 0.55
[ 1932472-17-7 ]
(3AS,6S,7aS)-8,8-dimethylhexahydro-3H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide
Similarity: 0.65
[ 108448-77-7 ]
(3aR,6S,7aS)-8,8-Dimethylhexahydro-1H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide
Similarity: 0.58
[ 122080-99-3 ]
3-Tosyl-3-azabicyclo[3.2.0]heptan-6-one
Similarity: 0.51